Aprameya Engineering Ltd

Aprameya Engineering Ltd IPO

IPO Price Range: ₹56 - 58

Aprameya Engineering Limited is engaged in the business of installation, set up & maintenance of Intensive Care Units (ICU), Neonatal Intensive Care Units (NICU), Pediatric Intensive Care Units (PICU), Operation Theatre, dialysis centres and prefabricated structure ward (hereinafter referred to as Healthcare Infrastructure projects) in the hospitals and medical care centres on turnkey basis along with supply of high value healthcare equipment and diagnostic equipment to private hospitals, Government hospitals and medical practitioners. Further, the company has many times received commission from the equipment suppliers for supply of the medical equipment directly to the customers.

Min Investment

₹1,16,000

IPO Size

₹29 Cr

IPO Status

Closed

Quantity in 1 Lot

2000

Max Bid allowed

1

Listing Exchange

NSE

IPO Application Timeline of Aprameya Engineering Ltd

Open Date25 Jul 2024
Close Date29 Jul 2024
Allotment Date30 Jul 2024
Listing Date1 Aug 2024

Key Statistics

Bid Opening DateBid Opening Date25 Jul 2024
Bid Closing DateBid Closing Date29 Jul 2024
Allotment DateAllotment Date30 Jul 2024
Issue SizeIssue Size₹29.23Cr
Quantity in 1 lotQuantity in 1 lot2000

Strength and risks

Strength

Strength

  • Rapid growth in the business with focus on setting up of healthcare infrastructure.

  • Track record of execution capabilities of setting up ICUs NICUs PICUs as well as Operation Theatre.

  • Firm arrangement with many medical equipment suppliers and manufacturers.

  • Wide customer base including many Private and Government Hospital /Medical college.

  • Experienced Promoters with technical team having domain knowledge.

  • Asset light scalable business model.


Risk

Risk

  • Loss of any of its key customers or significant reduction in demand from, its significant customers may materially and adversely affect its business and financial performance.

  • Many of its work orders are awarded primarily through competitive bidding processes. There is no assurance that future contracts will be awarded to it by these customers. Also, the tenders floated by the government agencies have terms that aresuitable to such agencies. This may result in an adverse effect on its business growth, financial and results of operations.

  • The company depends significantly on customers and their spending in the healthcare infrastructure industry and any decline in the spending on healthcare infrastructure in India, could adversely affect its business and profitability.

  • Its Order Book may not be representative of its future results and its actual income may be significantly less than the estimates reflected in its Order Book, which could adversely affect its results of operations.

  • The company has diversified into the business related to installation, set up & maintenance of ICU, NICU, PICU and Operation Theatre in the recent past and are subject to risks associated with new offerings and may not successfully implement its new business models.

  • The company faces risks relating to sourcing medical equipments from third parties. Failure of such third parties to meet their obligationscould adversely affect its business and results of operations.

  • Any delays in the completion of its current and future projects could lead to termination of work orders or cost overruns, which could have an adverse effect on its cash flows, business, results of operations and financial condition.

  • Certain of its properties, including the Registered Office, Branch Office and Warehouse are leased from its promoters, directors and third parties. There can be no assurance that these lease agreements will be renewed upon termination or that its will be able to obtain other premises on lease on same or similar commercial terms.

  • The company is required to obtain, renew or maintain certain statutory and regulatory permits and approvals required to operate its business and if its fail to do so in a timely manner or at all and its business, financial conditions, results of operations, and cash flows may be adversely affected.

  • The company derives a significant portion of its revenue from the state of Rajasthan and any adverse developments in these market could adversely affect its business.

Promoters Holding

Investors Holdings %
Saurabh Kishorebhai Bhatt49.29%
Chetan Mohan Joshi49.29%
Archana Chetan Joshi0.43%
Pooja Saurabh Bhatt0.43%

About Aprameya Engineering Ltd

OrganisationAprameya Engineering Ltd
HeadquartersAhmedabad
IndustryHealthcare

Frequently Asked Questions

  • What is the size of the Aprameya Engineering Ltd IPO?

    The size of the Aprameya Engineering Ltd IPO is ₹29.23Cr .

  • What is 'pre-apply' for Aprameya Engineering Ltd IPO?

    'Pre-apply' for Aprameya Engineering Ltd IPO indicates your interest in the IPO before it opens for subscription. This ensures quick application when the IPO goes live.

  • When will my Aprameya Engineering Ltd IPO order be placed?

    Your Aprameya Engineering Ltd IPO order will be placed on 25 Jul 2024.

  • What are the open and close dates of the Aprameya Engineering Ltd IPO?

    The open and close dates of the Aprameya Engineering Ltd IPO are 25 Jul 2024 to 29 Jul 2024.

  • What is the lot size and minimum order quantity of the Aprameya Engineering Ltd IPO?

    The lot size and minimum order quantity of the Aprameya Engineering Ltd IPO are 2000 and 2000 respectively.

  • What would be the listing gains on the Aprameya Engineering Ltd IPO?

    The potential listing gains on the Aprameya Engineering Ltd IPO will depend on various market factors and cannot be predicted with certainty.